Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma

Cancer

Volumn 94, Issue 12, 2002, Pages 3210-3218

  Arrieta, Oscar ^a,b   Garcia, Esperanza ^a   Guevara, Patricia ^a   Garcia Navarrete, Roberto ^a   Ondarza, Rodolfo ^a   Rembao, Daniel ^a   Sotelo, Julio ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Angiogenesis; Astrocytoma; Brain tumors; Glioblastoma; Hepatocyte growth factor; Meningioma

Indexed keywords

CYTOKINE; SCATTER FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER RECURRENCE; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; TUMOR DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CELL DIVISION; FEMALE; GLIOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROGNOSIS;

EID: 0037096867     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10594     Document Type: Article

References (67)

1. Brain Tumors
2. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota
3. Treatment of malignant glioma in adults
4. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
5. Brain tumors in Mexico; characteristics and prognosis of glioblastoma
6. Angiogenesis in malignat glioma
7. Tumor angiogenesis - A new therapeutic target in gliomas
8. Regulation of angiogenesis in malignant gliomas
9. Suppression of glioblastoma angiogenicity and tumorogenicity by inhibition of endogenous expression of vascular endothelial growth factor
10. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: A review
11. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells
12. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: Evidence for a role in progression of astrocytic tumors
13. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-Met, in gliomas, meningiomas and schwannomas in humans
14. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-Met genes in human glioma cells in vitro
15. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis
16. Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cyst
17. Growth factor profiles of human gliomas. Do non-tumor cells contribute to tumor growth in glioma?
18. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine
19. Fractionated radiation therapy in treatment of intracranial meningiomas: Local control, functional efficacy, and tolerance in 91 patients
20. Efficacy of conventional radiotherapy for recurrent meningioma
21. Plasma levels and hepatic mRNA expression of transforming factor-beta 1 in patients with hepatic fulminant failure
22. Scatter factor and hepatocyte growth factor: Activities, properties and mechanism
23. Hepatocyte growth factor: A multifunctional cytokine
24. Increased levels of human hepatocyte growth factor in serum and peritoneal fluid after partial hepatectomy
25. Human hepatocyte growth factor in bile: An indicator of posthepatectomy liver function in patients with biliary tract carcinoma
26. HGF: A multifunctional growth factor controlling cell scattering
27. Human hepatic myofibroblast increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor
28. Hepatocyte growth factor/scatter factor in the eye
29. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity
30. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
31. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen activated protein kinase pathways
32. Hepatocyte growth factor as a hematopoietic regulator
33. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
34. Different point mutations in the met oncogene elicit distinct biological properties
35. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells
36. Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer
37. Expression of c-Met is a strong independent prognostic factor in breast carcinoma
38. Targeting angiogenesis: Genetic intervention which strikes at the weak link of tumorigenesis
39. Expression of c-Met/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues
40. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma
41. Biological role of HGF/MET pathway in renal cell carcinoma
42. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells
43. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma
44. Expression of scatter factor in human bladder carcinoma
45. Tumor invasion: Role of growth factor-induced cell motility
46. Hepatocyte growth factor/scatter factor-induced intracellular signalling
47. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-Met) in human brain tissues
48. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas
49. Scatter factor/hepatocyte growth factor expression enhances human glioma tumorigenicity and growth
50. Met and hepatocyte growth factor/scatter factor expression in human gliomas
51. Peritumoral brain edema in meningiomas - Influence of vascular supply on its development
52. Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: An immunohistochemical study
53. Immunohistochemical examination of c-Met protein expression in astrocytic tumors
54. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways
55. Depressed T lymphocyte function in brain tumor patients: Monocytes as suppressor cells
56. In vitro modulation of microglia by glioma cells is mediated by hepatocyte growth factor/scatter factor
57. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice
58. The met receptor tyrosine kinase transduces motility, proliferation and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells
59. The interaction between Gab 1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
60. Necrosis as a prognostic factor in glioblastoma multiforme
61. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability
62. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor
63. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblastic growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy
64. Recurrence of meningiomas
65. MIB-1 staining index of pedriatic meningiomas
66. Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: A study of 60 tumors
67. Management of atypical and malignat meningiomas: Role of high-dose, 3D-conformal radiation therapy